BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023Conference call scheduled for 8:00 a.m. Eastern Time

  Ardelyx, Inc. today announced it will hold a conference call on Wednesday, August 2, 2023, at 8:00 a.m. Eastern Time to discuss second quarter financial results and provide a business update.

  July 26, 2023

   · 

  1 min read
• EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer

  EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it has received reimbursement approval in Switzerland for the use of High-Intensity Focused Ultrasound (HIFU) in the treatment of prostate cancer.

  July 26, 2023

   · 

  4 min read
• Drug Development

  Recce Pharmaceuticals Doses Subjects in Rapid Infusion Phase I/II UTI Clinical Trial of RECCE® 327 at Scientia Clinical Research

  Recce Pharmaceuticals Ltd is pleased to announce it dosed both male and female subjects in a Phase I/II urinary tract infection (UTI) clinical trial evaluating R327 at faster infusion rates at Scientia Clinical Research.

  July 26, 2023

   · 

  2 min read
• Business

  BrainsWay to Report Second Quarter 2023 Financial Results on August 9, 2023

  BrainsWay Ltd. today announced that it will report its second quarter 2023 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, August 9, 2023.

  July 26, 2023

   · 

  1 min read
• Business

  Fortive Reports Strong Second Quarter 2023 Results; Raises Full Year 2023 Outlook

  Fortive Corporation today announced financial results for the second quarter 2023.

  July 26, 2023

   · 

  28 min read
• Business

  Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023

  Axogen, Inc. today announced that it will report second quarter 2023 financial results on Monday, August 7, 2023 after the market closes.

  July 26, 2023

   · 

  2 min read
• Lone Star Bio

  Marker Therapeutics to Participate in Virtual Roundtable with Key Opinion Leaders to Discuss Clinical Landscape of CAR-T Cell Therapies on August 9, 2023

  Marker Therapeutics, Inc. today announced participation in a live webcast produced by Demy-Colton and sponsored by the WBB Research Institute titled “Beyond CAR-T, What’s Next for Cell Therapy”.

  July 26, 2023

   · 

  5 min read
• Business

  Karyopharm to Report Second Quarter 2023 Financial Results on August 2, 2023

  Karyopharm Therapeutics Inc. today announced it will report second quarter 2023 financial results on Wednesday, August 2, 2023.

  July 26, 2023

   · 

  2 min read
• Business

  Ionis to hold second quarter 2023 financial results webcast

  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, August 9th at 11:30 a.m. Eastern Time to discuss its second quarter 2023 financial results.

  July 26, 2023

   · 

  1 min read
• Business

  Children’s Hospital Colorado Launches State’s First Pediatric Precision Medicine Institute

  Children’s Hospital Colorado announced the launch of the Precision Medicine Institute, which will allow experts to more efficiently integrate precision medicine into care provided to patients throughout the hospital.

  July 26, 2023

   · 

  5 min read